Literature DB >> 16470404

Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns.

R De La Garza1, K R Fabrizio, A Gupta.   

Abstract

RATIONALE: Despite decades of research specifying harmful effects produced by 3,4-methylenedioxymethamphetamine (MDMA; a principal component of 'ecstasy' pills), young people (and adults) continue to use it. In an attempt to model human MDMA consumption patterns, preclinical investigators have sought to establish reliable patterns of intravenous MDMA self-administration in rodents.
OBJECTIVE: The objective of this report is to offer a critical review of published data (including our own novel findings) that reveal MDMA self-administration in rodents.
RESULTS: The data indicate that MDMA serves as a reinforcer in rodents, though the responses are not similar to those previously reported for psychostimulants (i.e., cocaine). Important differences between rodent models and human use patterns include frequency of dosing and dosage exposure, routes of administration, tolerance that develops to MDMA after repeated exposure, polydrug use in humans but not by rodents, limits on the repertoire of behaviors that can be exhibited by rodents undergoing IV self-administration procedures, and the question of neurotoxicity as it relates to models of self-administration.
CONCLUSIONS: While MDMA is not as potent a reinforcer as other drugs of abuse, the fact remains that young people and adults continue to use the drug, and therefore, additional research is needed to determine why drugs with low reinforcing effects continue to be abused.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470404     DOI: 10.1007/s00213-005-0255-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  59 in total

1.  Do vertical shifts in dose-response rate-relationships in operant conditioning procedures indicate "sensitization" to "drug wanting"?

Authors:  Gerald Zernig; Gudrun Wakonigg; Ekkehard Madlung; Christian Haring; Alois Saria
Journal:  Psychopharmacology (Berl)       Date:  2003-10-03       Impact factor: 4.530

2.  Increasing MDMA use among college students: results of a national survey.

Authors:  Jared Strote; Jae Eun Lee; Henry Wechsler
Journal:  J Adolesc Health       Date:  2002-01       Impact factor: 5.012

Review 3.  Serotonin and hallucinogens.

Authors:  G K Aghajanian; G J Marek
Journal:  Neuropsychopharmacology       Date:  1999-08       Impact factor: 7.853

4.  Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception.

Authors:  G Zernig; J W Lewis; J H Woods
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

5.  Evidence for addiction-like behavior in the rat.

Authors:  Véronique Deroche-Gamonet; David Belin; Pier Vincenzo Piazza
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

6.  The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

Authors:  E O'Shea; R Granados; B Esteban; M I Colado; A R Green
Journal:  Neuropharmacology       Date:  1998-07       Impact factor: 5.250

7.  Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

Authors:  A C Parrott; J Lasky
Journal:  Psychopharmacology (Berl)       Date:  1998-10       Impact factor: 4.530

8.  Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.

Authors:  W E Fantegrossi; J H Woods; G Winger
Journal:  Behav Pharmacol       Date:  2004-03       Impact factor: 2.293

9.  Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA.

Authors:  Marcy J Bubar; Kami M Pack; Paul S Frankel; Kathryn A Cunningham
Journal:  Psychopharmacology (Berl)       Date:  2004-04-03       Impact factor: 4.530

10.  Ecstasy and drug consumption patterns: a Canadian rave population study.

Authors:  Samantha R Gross; Sean P Barrett; John S Shestowsky; Robert O Pihl
Journal:  Can J Psychiatry       Date:  2002-08       Impact factor: 4.356

View more
  23 in total

1.  Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats.

Authors:  Pai-Kai Huang; Shawn M Aarde; Deepshikha Angrish; Karen L Houseknecht; Tobin J Dickerson; Michael A Taffe
Journal:  Drug Alcohol Depend       Date:  2012-06-03       Impact factor: 4.492

2.  Intravenous self-administration of entactogen-class stimulants in male rats.

Authors:  Sophia A Vandewater; Kevin M Creehan; Michael A Taffe
Journal:  Neuropharmacology       Date:  2015-08-21       Impact factor: 5.250

3.  Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.

Authors:  Charles W Schindler; Eric B Thorndike; Steven R Goldberg; Kurt R Lehner; Nicholas V Cozzi; Simon D Brandt; Michael H Baumann
Journal:  Psychopharmacology (Berl)       Date:  2015-08-29       Impact factor: 4.530

4.  Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues.

Authors:  Kevin T Ball; Kelly M Walsh; George V Rebec
Journal:  Pharmacol Biochem Behav       Date:  2007-06-02       Impact factor: 3.533

Review 5.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

6.  Estimating the relative reinforcing strength of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine.

Authors:  Zhixia Wang; William L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  2006-10-25       Impact factor: 4.530

7.  In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats.

Authors:  Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2015-05-01       Impact factor: 4.530

8.  Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions.

Authors:  Daniel L Albaugh; Jennifer A Rinker; Michael H Baumann; Jacquelyn R Sink; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2011-03-05       Impact factor: 4.530

9.  Intracranial self-administration of MDMA into the ventral striatum of the rat: differential roles of the nucleus accumbens shell, core, and olfactory tubercle.

Authors:  Rick Shin; Mei Qin; Zhong-Hua Liu; Satoshi Ikemoto
Journal:  Psychopharmacology (Berl)       Date:  2008-04-05       Impact factor: 4.530

10.  Age differences in (±) 3,4-methylenedioxymethamphetamine (MDMA)-induced conditioned taste aversions and monoaminergic levels.

Authors:  Jennifer L Cobuzzi; Kayla A Siletti; Zachary E Hurwitz; Bradley Wetzell; Michael H Baumann; Anthony L Riley
Journal:  Dev Psychobiol       Date:  2013-06-15       Impact factor: 3.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.